Patient Comments: Primary Sclerosing Cholangitis - Medications

Question:

What medications were helpful with the symptoms you experienced with primary sclerosing cholangitis? Submit Your Comment

Comment from: M66Maryann, 45-54 Female (Patient) Published: May 30

My itching was severe with primary sclerosing cholangitis. I felt desperate and could not function normally. Nor could I sleep normally. Prior to diagnosis, I had taken sertraline for several years to treat anxiety. I weaned myself from it, and promptly began itching. In hindsight, I believe the sertraline had prevented the itching. After diagnosis, I got back on it. It did nothing to relieve the itching. I tried hydroxyzine, ursodiol, rifampin, and cyproheptadine. None worked. Cholestyramine worked. It is a powder that you mix into a liquid and drink. I take 3 doses daily, along with sertraline, and cyproheptadine. It took about 2 weeks to handle the itching.

Comment from: Jason, 45-54 Male (Patient) Published: February 07

Ursofalk (ursodeoxycholic acid) greatly reduced the pain I experienced in my liver because of primary sclerosing cholangitis. If I stop taking it (forget to take or run out), the pain increases so it definitely makes a difference. It does not reduce the disease, but does reduce the pain. Questran Light (cholestyramine anhydrous) reduced extreme itchiness.

Comment from: sundance, 55-64 Male (Patient) Published: October 14

I was prescribed ursodiol upon diagnosis of primary sclerosing cholangitis in 2006 and have been using it ever since. Since taking it I have not experienced another septic episode. However, my most recent MRI did reveal a new stricture in my bile duct which confirms that ursodiol does not impede progression of the disease.

QUESTION

Liver disease refers to any abnormal process that affects the liver. See Answer

Subscribe to MedicineNet's General Health Newsletter

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

CONTINUE SCROLLING FOR RELATED SLIDESHOW